Literature DB >> 34528774

Re: Pre-operative COVID-19 screening for urologic patients.

Pathum Sookaromdee1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 34528774      PMCID: PMC8691253          DOI: 10.1590/S1677-5538.IBJU.2021.0245

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


× No keyword cloud information.
To the editor, We would like to share ideas on the publication “Pre-operative COVID-19 screening: a model to provide non-discretionary care for urologic patients” Ferenczi et al. (1). concluded that “Universal COVID-19screening of pre-operative patients represents aviable means to meet the needs of our patients” (1). Since COVID-19 might be asymptomatic, a COVID-19 screening is a useful preventive measure. Nevertheless, there are some important considerations. First, the cost of screening should be considered. A cost effective screening tool should be selected. Second, any test can provide a false result and limitation of sensitivity might be problematic (2). Universal preventive guidelines are still important. The practitioner has to strict follow the standard universal prevention protocols. Finally, it is necessary to set a good method for management of a positive case. If a positive result is the cause of under standardized clinical management, it is considered unethical. Since there is no present recommendation for specific therapy for COVID-19, further researches are necessary (3). The Authors
  3 in total

1.  False negative RT-PCR and false positive antibody tests-Concern and solutions in the diagnosis of COVID-19.

Authors:  Xingwang Jia; Liehui Xiao; Yajie Liu
Journal:  J Infect       Date:  2020-10-08       Impact factor: 6.072

Review 2.  Treatment and research lines for the patient with COVID-19. What do we have and where are we going?

Authors:  Carolina Gotera
Journal:  Int Braz J Urol       Date:  2020-07       Impact factor: 1.541

3.  Pre-operative COVID-19 screening: a model to provide non-discretionary care for urologic patients.

Authors:  Basil A Ferenczi; Ron Ron Cheng; Adam Daily; Christian Kuhr; Kathleen Kobashi; John M Corman
Journal:  Int Braz J Urol       Date:  2021 May-Jun       Impact factor: 1.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.